Trodelvy

What Trodelvy Means in Everyday Medical Language

Trodelvy is the brand name for sacituzumab govitecan, a cancer treatment drug used mainly for certain types of advanced breast cancer. It is a special kind of medicine called an antibody-drug conjugate. This means it combines an antibody—a protein designed to find and attach to cancer cells—with a chemotherapy drug that can kill those cells. The antibody part of Trodelvy targets a protein called TROP2, which is found on the surface of some cancer cells, especially in triple-negative and hormone receptor–positive, HER2-negative breast cancers. Once attached, the chemotherapy drug SN-38 is delivered directly into the cancer cells to damage their DNA and help stop their growth.

Why Trodelvy Can Matter in Cancer Care

Trodelvy offers a treatment option for adults with advanced breast cancers that have spread or cannot be removed by surgery, especially when other treatments have not worked. Triple-negative breast cancer (TNBC) is a type that lacks certain receptors, making it harder to treat with hormone or HER2-targeted therapies. Trodelvy’s targeted approach helps deliver chemotherapy directly to cancer cells, which can improve effectiveness and reduce damage to healthy cells. It is approved for patients who have already tried other therapies, providing hope for those with limited options. Trodelvy is also being studied for other cancers, showing ongoing research interest.

What Patients Might See, Feel, or Hear About Trodelvy

Patients may hear the name Trodelvy or sacituzumab govitecan during discussions about treatment options for advanced breast cancer. Doctors will explain that this drug targets cancer cells specifically and delivers chemotherapy directly to them. Treatment is given through an intravenous (IV) infusion, usually on a schedule such as days one and eight every 21 days. Common side effects include nausea, diarrhea, low white blood cell counts (which can increase infection risk), fatigue, hair loss, and others. Because of these risks, patients are closely monitored during treatment. Understanding these effects can help patients prepare and communicate with their care team.

Where Trodelvy May Appear in Medical Care

You might see Trodelvy or sacituzumab govitecan mentioned in medical records, treatment plans, or reports if you or a loved one is receiving this drug. It may also appear in information about clinical trials or on drug information pages from trusted sources like the National Cancer Institute or MedlinePlus. Knowing that Trodelvy and sacituzumab govitecan refer to the same drug can help avoid confusion when reading different materials. Clinical trials continue to explore its use in other cancers beyond breast cancer.

Common Questions and Considerations for Patients

Patients and caregivers may want to ask their care team about how Trodelvy works, what side effects to expect, and how it fits into the overall treatment plan. It is important to discuss any other medications being taken to avoid interactions. Since Trodelvy is approved for specific types of breast cancer after other treatments, patients might ask about eligibility and whether clinical trials are available for other cancers. Understanding the monitoring needed during treatment can help patients feel more prepared and supported.

Safety and Context

This information is educational and does not replace medical advice. Trodelvy can cause serious side effects, including low white blood cell counts and diarrhea, which require close monitoring. It may also harm a developing fetus or newborn, so pregnancy precautions are important. Always talk with your healthcare provider about what is safe and appropriate for your individual situation. Your care team can provide guidance tailored to your health needs.

Next Steps for Patients and Caregivers

If you see the term Trodelvy or sacituzumab govitecan in your medical records or hear it during discussions, the best next step is to ask your healthcare team what it means for your specific diagnosis and treatment plan. They can explain how this drug might help, what to expect during treatment, and answer any questions you have. Staying informed and involved in your care helps you make the best decisions together with your care team.